tirzepatide bmi (ZEPBOUND) Approved for Chronic Weight Management in Adults with Obesity ✨ The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI of 30 kg/ m2 or Tirzepatide on ingestive behavior in

Semaglutide, a glucagon like peptide-1 analogue, lowers blood glucose, but does it increase cardiovascular risk

Frontiers in Public Health , 12 , 1385387

Emergency Warning Signs Seek immediate medical attention for: Sudden vision loss in one eye (painless or otherwise) Persistent new floaters lasting more than 2 weeks Flashes of light or curtain-like vision loss New dark spots or curtain across vision Sudden changes in color vision Any abrupt, unexplained vision changes Ongoing Monitoring Schedule Non-diabetic patients: Annual comprehensive eye exams Diabetic patients without retinopathy: Annual dilated exams Diabetic patients with existing retinopathy: Quarterly exams during year 1, then as recommended Healthcare providers should also assess optic nerve anatomy

Semaglutide works by acting like a natural gut hormone that helps the body release insulin when blood sugar is high, reduces the amount of sugar made by the liver, and slows stomach emptying